Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2679 |
BMS-265246
BMS265246 |
CDK | Cell Cycle/Checkpoint |
BMS-265246 是一种有效的选择性 CDK1/2 抑制剂,对 CDK1/cyclin B 和 CDK2/cyclin E 的 IC50分别为6 nM 和9 nM。 | |||
T8498 |
EIDD-1931
Beta-d-N4-hydroxycytidine |
Virus Protease; HCV Protease; SARS-CoV; Topoisomerase | DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
EIDD-1931 (Beta-d-N4-hydroxycytidine) 是一种核苷类抗病毒试剂 ,可抑制丙型肝炎病毒、基孔肯亚病毒和委内瑞拉马脑炎病毒的复制活性。 | |||
T81206 | SARS-CoV-2-IN-65 | SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-65(compound 2f(81))是一种具有口服活性的有效可逆SARS-CoV-2进入抑制剂。它通过抑制Calu-3细胞中RBD:ACE2的相互作用和TMPRSS2的活性,阻断了假病毒通过ACE2依赖性途径的进入。 | |||
T79245 |
SARS-CoV-2-IN-45
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-45(Compound 8p)是SARS-CoV-2的有效抑制剂,能够在Calu-3细胞中抑制病毒复制,其EC50值为0.5 μM,同时没有显著的细胞毒性。 | |||
T81209 |
SARS-CoV-2-IN-62
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-62 (Compound R3b) 为SARS-CoV-2复制抑制剂,细胞毒性较低。在Vero E6细胞和Calu-3细胞中,其抑制病毒复制的EC50值分别为2.97 μM与3.82 μM。 | |||
T79244 |
SARS-CoV-2-IN-44
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-44为SARS-CoV-2的抑制剂,其EC50为0.6 μM,能有效抑制病毒复制。该化合物在Calu-3细胞中未观察到明显细胞毒性,适用于抗病毒研究。 | |||
T81208 |
SARS-CoV-2-IN-63
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-63(Compound R3e)是一种针对SARS-CoV-2病毒复制的抑制剂,具备较低的细胞毒性。在Vero E6细胞和Calu-3细胞中对SARS-CoV-2的抑制作用表现出EC50值分别为1.99 μM与1.92 μM。 | |||
T69035 | Camostat free base | ||
Camostat, also known as FOY 305, is a serine protease inhibitor. Camostat is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis. It is an inhibitor of the enzyme transmembrane protease, serine 2 (TMPRSS2). Inhibition of TMPRSS2 partially blocked infection by SARS-CoV and Human coronavirus NL63 in HeLa cell cultures. In vitro study showed that camostat significantly reduces... |